One of the main features of both T2D and MetS onset is insulin resistance, defined as an inability of the target tissues to orchestrate well-coordinated glucose-lowering processes such as the suppression of gluconeogenesis, lipolysis, net glycogen synthesis, and cellular glucose uptake in response to physiological insulin levels in plasma [5]. This evidence concerns the gene INS and Insulin resistance.